Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment
Basel, January 9, 2026 – Novartis, a leading global innovative medicines company,…
ICPO Foundation co-founded the RLT Angels Association with the aim of growing access to Radiotheranostics to one million patients
Further founding members include the European Association of Nuclear Medicine (EANM), GE…
Clarivate Identifies Radioligand Therapy Innovators as Companies to Watch in the Future of Precision Oncology
New Report Highlights Emerging Leaders Advancing Next-generation Radiopharmaceuticals, Reshaping Cancer Care Through…
